+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential activity of topoisomerase I inhibitors in multidrug resistance protein and P170-glycoprotein mediated multidrug resistance



Differential activity of topoisomerase I inhibitors in multidrug resistance protein and P170-glycoprotein mediated multidrug resistance



Proceedings of the American Association for Cancer Research Annual Meeting 37: 441




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030926831

Download citation: RISBibTeXText


Related references

Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells. International Journal of Urology 4(6): 583-590, 1997

Multidrug resistance modulation by the taxane derivatives IDN-5109 and tRA96023 Effects on P-glycoprotein -, multidrug resistance protein -, and breast cancer resistance protein - mediated drug transport. Proceedings of the American Association for Cancer Research Annual Meeting 43: 950, 2002

The Pipecolinate Derivatives VX-710 and VX-853 Are Effective Modulators of Drug Efflux Mediated by the Multidrug Resistance Proteins P-Glycoprotein, Multidrug Resistance Protein and Breast Cancer Resistance Protein in Acute Myeloid Leukemia Cells. Blood 100(11): Abstract No 245, 2002

The pipecolinate derivative VX-710 modulates multidrug resistance mediated by P-glycoprotein , multidrug resistance protein and breast cancer resistance protein. Proceedings of the American Association for Cancer Research Annual Meeting 44: 112, 2003

Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives. Biological and Pharmaceutical Bulletin 31(6): 1258-1264, 2008

Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes. European Journal of Biochemistry 252(1): 140-146, 1998

Relationship between P-glycoprotein, multidrug resistance-associated protein, and cellular accumulation of topoisomerase I inhibitors. Proceedings of the American Association for Cancer Research Annual Meeting 37: 312, 1996

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein. British Journal of Cancer 77(3): 359-365, 1998

Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line. International Journal of Cancer 57(2): 229-239, 1994

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clinical Cancer Research 5(10): 2798-2805, 1999

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. Journal of Urology 170(4 Pt 1): 1383-1387, 2003

P-glycoprotein , multidrug-resistance related protein and lung resistance protein multidrug resistance phenotypes in peripheral blood and bone marrow. Proceedings of the American Association for Cancer Research Annual Meeting 38: 388, 1997

Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein. Surgery Today 29(5): 401-406, 1999

Expression patterns of multidrug-resistance , multidrug resistance-associated protein , glutathione-S-transferase-pi and DNA topoisomerase II genes in renal cell carcinomas and normal kidney. Journal of Urology 156(2 Part 1): 506-511, 1996

Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney. Journal of Urology 156(2 Part 1): 506-511, 1996